243 related articles for article (PubMed ID: 28235545)
1. Clinical and neurocognitive aspects of hallucinations in Alzheimer's disease.
El Haj M; Roche J; Jardri R; Kapogiannis D; Gallouj K; Antoine P
Neurosci Biobehav Rev; 2017 Dec; 83():713-720. PubMed ID: 28235545
[TBL] [Abstract][Full Text] [Related]
2. Minor Hallucinations in Alzheimer's Disease.
Ruiz M; Arias A; Sánchez-Llanos E; Gil MP; López-Ortega R; Dakterzada F; Purroy F; Piñol-Ripoll G
J Alzheimers Dis; 2018; 64(2):543-549. PubMed ID: 29889069
[TBL] [Abstract][Full Text] [Related]
3. Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates.
Bassiony MM; Steinberg MS; Warren A; Rosenblatt A; Baker AS; Lyketsos CG
Int J Geriatr Psychiatry; 2000 Feb; 15(2):99-107. PubMed ID: 10679840
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical correlates of psychotic symptoms in Alzheimer's disease.
Gormley N; Rizwan MR
Int J Geriatr Psychiatry; 1998 Jun; 13(6):410-4. PubMed ID: 9658277
[TBL] [Abstract][Full Text] [Related]
5. Clinical variables associated with psychosis in Alzheimer's disease.
Kotrla KJ; Chacko RC; Harper RG; Doody R
Am J Psychiatry; 1995 Sep; 152(9):1377-9. PubMed ID: 7653698
[TBL] [Abstract][Full Text] [Related]
6. Cognitive impairment in studies of 5HTTLPR and psychosis in Alzheimer's disease: a systematic review.
Creese B; Ballard C; Jones E
Dement Geriatr Cogn Disord; 2013; 35(3-4):155-64. PubMed ID: 23392273
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for behavioral abnormalities in mild cognitive impairment and mild Alzheimer's disease.
Apostolova LG; Di LJ; Duffy EL; Brook J; Elashoff D; Tseng CH; Fairbanks L; Cummings JL
Dement Geriatr Cogn Disord; 2014; 37(5-6):315-26. PubMed ID: 24481207
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in the G720/G30 gene locus (DAOA) influences the occurrence of psychotic symptoms in patients with Alzheimer's disease.
Di Maria E; Bonvicini C; Bonomini C; Alberici A; Zanetti O; Gennarelli M
J Alzheimers Dis; 2009; 18(4):953-60. PubMed ID: 20009237
[TBL] [Abstract][Full Text] [Related]
9. Anxiety symptoms are quantitatively and qualitatively different in dementia with Lewy bodies than in Alzheimer's disease in the years preceding clinical diagnosis.
Segers K; Benoit F; Meyts JM; Surquin M
Psychogeriatrics; 2020 May; 20(3):242-246. PubMed ID: 31782249
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease with delusions and hallucinations: neuropsychological and electroencephalographic correlates.
Lopez OL; Becker JT; Brenner RP; Rosen J; Bajulaiye OI; Reynolds CF
Neurology; 1991 Jun; 41(6):906-12. PubMed ID: 2046938
[TBL] [Abstract][Full Text] [Related]
11. [Presentation and stability of cognitive and noncognitive symptom patterns in patients with Alzheimer's disease. Disease course over a two-year period under constant treatment conditions with rivastigmine].
Wobrock T; Retz-Junginger P; Retz W; Supprian T; Rösler M
Fortschr Neurol Psychiatr; 2003 Apr; 71(4):199-204. PubMed ID: 12677553
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's Disease-Related Psychosis: An Overview of Clinical Manifestations, Pathogenesis, and Current Treatment.
Benmelouka AY; Ouerdane Y; Outani O; Alnasser YT; Alghamdi BS; Perveen A; Ashraf GM; Ebada MA
Curr Alzheimer Res; 2022; 19(4):285-301. PubMed ID: 35440308
[TBL] [Abstract][Full Text] [Related]
13. Olfactory hallucinations in Alzheimer's disease.
El Haj M; Larøi F
Acta Neuropsychiatr; 2021 Feb; 33(1):37-42. PubMed ID: 32981566
[TBL] [Abstract][Full Text] [Related]
14. Hallucinations and Delusions Signal Alzheimer's Associated Cognitive Dysfunction More Strongly Compared to Other Neuropsychiatric Symptoms.
Fuller JT; Choudhury TK; Lowe DA; Balsis S;
J Gerontol B Psychol Sci Soc Sci; 2020 Oct; 75(9):1894-1904. PubMed ID: 30877750
[TBL] [Abstract][Full Text] [Related]
15. Delusions and hallucinations are associated with worse outcome in Alzheimer disease.
Scarmeas N; Brandt J; Albert M; Hadjigeorgiou G; Papadimitriou A; Dubois B; Sarazin M; Devanand D; Honig L; Marder K; Bell K; Wegesin D; Blacker D; Stern Y
Arch Neurol; 2005 Oct; 62(10):1601-8. PubMed ID: 16216946
[TBL] [Abstract][Full Text] [Related]
16. Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease.
Qian W; Fischer CE; Schweizer TA; Munoz DG
Curr Alzheimer Res; 2018; 15(2):187-194. PubMed ID: 28847281
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis of psychological and behavioural disorders in Alzheimer's disease].
Pancrazi MP; Metais P
Presse Med; 2005 May; 34(9):661-6, 660. PubMed ID: 15988345
[TBL] [Abstract][Full Text] [Related]
18. Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease.
Fischer CE; Qian W; Schweizer TA; Millikin CP; Ismail Z; Smith EE; Lix LM; Shelton P; Munoz DG
J Alzheimers Dis; 2016; 50(1):283-95. PubMed ID: 26682680
[TBL] [Abstract][Full Text] [Related]
19. [Psychotic symptoms and Alzheimer's disease].
Alberca R; Gil-Néciga E; Salas D; Pérez JA; Lozano P
Neurologia; 2000 Jan; 15(1):8-14. PubMed ID: 10730061
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and psychological symptoms in Taiwanese patients with Alzheimer's disease.
Liu CY; Wang PN; Lin KN; Liu HC
Int Psychogeriatr; 2007 Jun; 19(3):605-13. PubMed ID: 17367555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
